Charles River Laboratories to Present at Raymond James Conference
WILMINGTON, Mass., Mar 03, 2008 (BUSINESS WIRE) -- Charles River Laboratories International, Inc. (NYSE:CRL) announced today that Chairman, President and Chief Executive Officer James C. Foster will present at the Raymond James 29th Annual Institutional Investors Conference in Orlando, Florida on Tuesday, March 4th at 1:05 p.m. ET. Mr. Foster will present an overview of Charles River's strategic focus and business developments.
A live webcast of the presentation will be available through a link that will be posted on the Investor Relations section of the Charles River Laboratories website at http://ir.criver.com. A webcast replay will be accessible through the same website approximately three hours after the presentation and will remain available through March 18, 2008.
SOURCE: Charles River Laboratories International, Inc.
CONTACT: Charles River Laboratories International, Inc. Investor Relations Contact:Susan E. Hardy, 781-222-6190Corporate Vice President, Investor Relations
For more information, contact us at:
*indicates a required field.
The information you provided will be kept confidential.
The Charles River Animal Welfare department has made recent strides in further integrating the 3Rs into our operations. Charles River representatives are acting as ambassadors within the industry to elevate the importance of animal welfare in laboratory animal research
Through this agreement, Charles River will sell the Axcess™ System, an offering that combines the Bruker MALDI Biotyper system with a custom data analysis software solution that allows instantaneous access to the Accugenix® microbial database for identifications.
Jun 22–Jun 26
Founded in 1960, the Teratology Society is a multidisciplinary society drawing its members from academia, industry and government. In addition to being an exhibitor, Charles River is pleased to be a platinum level sponsor and to be participating in this year’s meeting with multiple posters presentations.
May 20–May 22
Please visit Charles River tabletop #611 to discuss our full portfolio of products and services, including our Preclinical Services, as well as our Biopharmaceutical Services, which deliver client-focused solutions for the specific testing and manufacturing requirements of your biologic.
May 23–May 23
This full-day seminar encompasses selected topics from our Charles River Short Course on Laboratory Animal Science. We would like to acknowledge Michigan State University for hosting this event and extend our heartfelt thanks to guest speaker Dr. Danielle Ferguson.
This position is responsible for managing international aspects of US Federal income tax compliance; assisting with international tax planning, including identification of planning opportunities, designing and implementing plans, and transfer pricing process; overseeing quarterly ETR forecast process; and participating in the tax provision process, including assessment of tax risks, documentation of key positions, and review of non-US tax provision submissions.
This position is responsible for serving as a as a study director (SD), project scientist (PS) and/or principal investigator (PI) in the direction and execution of assigned studies in compliance with GLP regulations as they apply to the conduct of nonclinical research; coordinating all phases of the study planning process with appropriate departments; generating high-quality project plans, protocols, amendments and reports appropriate for assigned studies; reviewing, interpreting, integrating and presenting data on assigned studies; and functioning as contact for the planning and execution of sponsor interaction related to assigned studies, including proposal management and study scheduling, conduct and reporting.
Charles River Laboratories, Inc.